Terms: = Gastric cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9
1475 results:
1. EGFR and PI3K Signalling Pathways as Promising Targets on Circulating Tumour Cells from Patients with metastatic gastric Adenocarcinoma.
Piper AK; Penney C; Holliday J; Tincknell G; Ma Y; Napaki S; Pantel K; Brungs D; Ranson M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791602
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative abnormal bone mineral density as a prognostic indicator in patients undergoing gastrectomy for gastric cancer: A cohort study.
An S; Eo W
Medicine (Baltimore); 2024 May; 103(21):e38251. PubMed ID: 38788023
[TBL] [Abstract] [Full Text] [Related]
3. The efficacy and safety of apatinib combined with S-1 for advanced gastric cancer: A systematic review and meta-analysis.
Chen X; Wan L; He Y; Zhang Q; Zheng X
Medicine (Baltimore); 2024 May; 103(21):e38272. PubMed ID: 38787998
[TBL] [Abstract] [Full Text] [Related]
4. Characteristics and prognostic impact of cancer cachexia defined by the Asian Working Group for Cachexia consensus in patients with curable gastric cancer.
Zhang FM; Zhuang CL; Dong QT; Yu Z; Cheng J; Shen X; Wang SL
Clin Nutr; 2024 Jun; 43(6):1524-1531. PubMed ID: 38744096
[TBL] [Abstract] [Full Text] [Related]
5. Enhanced recovery after surgery after radical gastrectomy: Improved compliance over time is associated with a shorter postoperative hospital stay.
Tankel J; Kammili A; Meng A; Dehghani M; Sakalla R; Spicer J; Najmeh S; Cools-Lartigue J; Ferri L; Mueller C
World J Surg; 2024 Feb; 48(2):261-270. PubMed ID: 38686766
[TBL] [Abstract] [Full Text] [Related]
6. Impact of Gastrojejunostomy Anastomosis Diameter on Weight Loss Following Laparoscopic gastric Bypass: A Systematic Review.
Al-Fagih OS; Zuberi S; Niaz O; Jambulingam P; Whitelaw D; Rashid F; Adil MT; Jain V; Al-Taan O; Munasinghe A; Askari A; Iqbal FM
Obes Surg; 2024 Jun; 34(6):2227-2236. PubMed ID: 38652437
[TBL] [Abstract] [Full Text] [Related]
7. The outcomes of laparoscopic omentum-preserving gastrectomy compared to open surgery with omentectomy in gastric cancer patients: a propensity score matched study of 249 UICC stage 0-IV gastric cancer patients.
Jagric T; Hladnik G; Kolaric R; Arpad I; Horvat M; Potrc S
Surg Endosc; 2024 Jun; 38(6):3096-3105. PubMed ID: 38622224
[TBL] [Abstract] [Full Text] [Related]
8. The Molecular Landscape of gastric cancers for Novel Targeted Therapies from Real-World Genomic Profiling.
Yamamoto H; Arai H; Oikawa R; Umemoto K; Takeda H; Mizukami T; Kubota Y; Doi A; Horie Y; Ogura T; Izawa N; Moore JA; Sokol ES; Sunakawa Y
Target Oncol; 2024 May; 19(3):459-471. PubMed ID: 38613733
[TBL] [Abstract] [Full Text] [Related]
9. Association of Helicobacter pylori CagA seropositivity with gastric precancerous lesions: a systematic review and meta-analysis.
Qiao Z; Wang E; Bao B; Tan X; Yuan L; Wang D
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):687-694. PubMed ID: 38526941
[TBL] [Abstract] [Full Text] [Related]
10. Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE.
Cartwright E; Slater S; Saffery C; Tran A; Turkes F; Smith G; Aresu M; Kohoutova D; Terlizzo M; Zhitkov O; Rana I; Johnston EW; Sanna I; Smyth E; Mansoor W; Fribbens C; Rao S; Chau I; Starling N; Cunningham D
ESMO Open; 2024 Apr; 9(4):102971. PubMed ID: 38518549
[TBL] [Abstract] [Full Text] [Related]
11. Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses.
Kelly RJ; Landon BV; Zaidi AH; Singh D; Canzoniero JV; Balan A; Hales RK; Voong KR; Battafarano RJ; Jobe BA; Yang SC; Broderick S; Ha J; Marrone KA; Pereira G; Rao N; Borole A; Karaindrou K; Belcaid Z; White JR; Ke S; Amjad AI; Weksler B; Shin EJ; Thompson E; Smith KN; Pardoll DM; Hu C; Feliciano JL; Anagnostou V; Lam VK
Nat Med; 2024 Apr; 30(4):1023-1034. PubMed ID: 38504015
[TBL] [Abstract] [Full Text] [Related]
12. Lymph node metastases are more frequent in paediatric appendiceal NET ≥1.5 cm but without impact on outcome - Data from the German met studies.
Kuhlen M; Kunstreich M; Pape UF; Seitz G; Lessel L; Vokuhl C; Frühwald MC; Vorwerk P; Redlich A
Eur J Surg Oncol; 2024 Apr; 50(4):108051. PubMed ID: 38430702
[TBL] [Abstract] [Full Text] [Related]
13. Advances in targeted therapy for gastric cancer based on tumor driver genes.
Wu S; Xu P; Zhang F
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 53(1):73-83. PubMed ID: 38413217
[TBL] [Abstract] [Full Text] [Related]
14. Association of HLA gene polymorphisms with Helicobacter pylori related gastric cancer-a systematic review.
Mahmud MT; Ahmed F; Rana MJ; Rahman MA; Atta A; Saif-Ur-Rahman KM
HLA; 2024 Feb; 103(2):e15394. PubMed ID: 38372631
[TBL] [Abstract] [Full Text] [Related]
15. Comparison of bioelectrical impedance analysis and computed tomography for the assessment of muscle mass in patients with gastric cancer.
Zuo J; Zhou D; Zhang L; Zhou X; Gao X; Hou W; Wang C; Jiang P; Wang X
Nutrition; 2024 May; 121():112363. PubMed ID: 38359703
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of Tepotinib, Paclitaxel, or Ramucirumab Efficacy According to the Copy Number or Phosphorylation Status of the
Sohn SH; Sul HJ; Kim BJ; Zang DY
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339049
[TBL] [Abstract] [Full Text] [Related]
17. A robust and validated LC-MS/MS method for the quantification of ramucirumab in rat and human serum using direct enzymatic digestion without immunoassay.
Huang WS; Li WQ; Yu X; Xue MZ; Yuan YL; Chen C; Wu YL; Yu JH; Diao XX
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1234():123991. PubMed ID: 38266611
[TBL] [Abstract] [Full Text] [Related]
18. Spontaneous tumour lysis secondary to gastric adenocarcinoma.
Prasad A; Verghese D; Vijaya Rangan S; Sunadarajan N
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38191220
[TBL] [Abstract] [Full Text] [Related]
19. Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial.
Lin JX; Tang YH; Zheng HL; Ye K; Cai JC; Cai LS; Lin W; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Zheng CH; Li P; Huang CM
Nat Commun; 2024 Jan; 15(1):41. PubMed ID: 38167806
[TBL] [Abstract] [Full Text] [Related]
20. The role of α7-nAChR-mediated PI3K/AKT pathway in lung cancer induced by nicotine.
He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
[TBL] [Abstract] [Full Text] [Related]
[Next]
